FDA Inspection 1198469 — Charles M. Fogarty, M.D.
The FDA completed an inspection of Charles M. Fogarty, M.D. on February 15, 2023 in Spartanburg, SC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 15, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Spartanburg, SC (United States)
Additional Details
Clinical Investigator (CI)